Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Aceto Names New Head For Specialty Chemicals Business Segment
Mr Weaving joined Aceto in 1984 and over the years has held various positions in the specialty chemicals business segment. Vincent Miata, president and CEO at Aceto, said:
Mr Weaving joined Aceto in 1984 and over the years has held various positions in the specialty chemicals business segment. Vincent Miata, president and CEO at Aceto, said:
The US Secretary of Health and Human Services has declared a public health emergency because of the outbreak of the pandemic flu virus. The FDA has issued emergency
The new service is based on an 80-gene signature that identifies the basal-like, luminal-like, and HER2 molecular subtypes in breast cancer tumors. MammaPrint is the breast cancer recurrence
Bausch + Lomb said that the bottle’s design and development was made possible through a partnership with Amcor Rigid Plastics, a producer of PET packaging and R&D/Leverage, known
GT said that the study, which is the basis for seeking FDA approval, also indicated that nearly 40% of women without disease could have avoided potentially painful and
Quintiles said that the expansion of the facility was the result of the collaboration with two UK-based institutions Guy’s and St Thomas’ NHS Foundation Trust and King’s College
The study is thought to be the first ever demonstration in humans of targeted siRNA-containing nanoparticle delivery to tumors using systemic administration, delivery of functional siRNAs, and achievement
The FDA enforcement action will likely result in a consent decree, under which a third party would inspect and review the plant’s operation for an extended period and
The Phase 2b trial is a randomized, open-label, multi-center, active-controlled, dose-ranging study to evaluate the safety and efficacy of albinterferon alfa-2b administered every four weeks plus daily ribavirin
The xdiscover library is a proprietary collection of more than 2000 primarily venom-derived peptides and is the result of a unique genomics capability that allows for the highly